Femme Homme
- | Pays : -
- | Organes : -
- | Spécialités : -
Extrait
• To evaluate the efficacy of GDC-0810 compared with fulvestrant in the intent to treat (ITT) population as measured by progression free survival (PFS) • To evaluate the efficacy of GDC-0810 compared with fulvestrant in the estrogen receptor 1 (ESR1) mutant population as measured by PFS
Critère d'inclusion
- Advanced or Metastatic ER+/HER2- Breast Cancer